Placebo Studies should not be Undertaken in Neuromyelitis Optica: Commentary

Abstract

Get full access to this article

View all access options for this article.

References

Weinshenker

Barron

Behne

. Challenges and opportunities in designing clinical trials for neuromyelitis optica. Neurology 2015 (forthcoming).

Kleinschmidt-DeMasters

Miravalle

Schowinsky

. Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab. J Neuropath Exp Neurol 2012; 71: 604–617.

Coles

. Alemtuzumab therapy for multiple sclerosis. Neurotherapeutics 2013; 10: 29–33.

Benatar

Verdugo

Salinas

. Thymectomy for non-thymomatous myasthenia gravis. Cochrane Database Syst Rev 2013; 10: CD008111.

Kaminski

Jaretzki

3rd Swan

Newsom-Davis

. Development of a thymectomy trial in nonthymomatous myasthenia gravis patients receiving immunosuppressive therapy. Annals of the New York Academy of Sciences 2003; 998: 473–480.

Kimbrough

Fujihara

Jacob

. Treatment of neuromyelitis optica: Review and recommendations. Multiple Sclerosis and Related Disorders 2012; 1: 180–187.